Yep ticking of 'drug-drug' interactions is an important step. CSL112 will generate enormous revenues for CSL if approved and will make them easily biggest company in Australia by market cap. One beautiful thing about that drug is the company already has the starting product ready to go...
All IMO DYOR
building the case for csl112, page-11
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$288.93 |
Change
0.320(0.11%) |
Mkt cap ! $139.9B | |||
| Open | High | Low | Value | Volume |
| $287.64 | $289.70 | $287.16 | $174.5M | 601.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 149 | $288.79 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $288.96 | 1858 | 1 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| CSL (ASX) Chart |